Form D · Business Services
Nephron Pharmaceuticals Corp
Orlando, FL · CIK 0001617435
Offering snapshot reported Aug 21, 2014 · SEC filing
- Reported sold
- $75M Offering amount: $75M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $475K Reported outside-investor minimum
- First sale
- Aug 7, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2014 | Initial | $75,000,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $500K
- Finders' fees
- $0
- Form D file number
- Not reported
Contingent advisory fee due upon closing of transaction
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Huron Transaction Advisory LLC | 166959 |
Source: Form D, filed Aug 21, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lou Wood Kennedy | Director, Executive |
| William P. Kennedy | Director |
Issuer details
Industry: Business Services (See others in industry)
Address:
3855 St. Valentine Way
Orlando, FL, 32811
Orlando, FL, 32811